Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients ; volume:11 ; number:1 ; day:31 ; month:5 ; year:2011 ; pages:1-9 ; date:12.2011
BMC cancer ; 11, Heft 1 (31.5.2011), 1-9, 12.2011
- Creator
-
Legge, Francesco
- Contributor
-
Paglia, Amelia
D'Asta, Marco
Fuoco, Gilda
Scambia, Giovanni
Ferrandina, Gabriella
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-11-214
- URN
-
urn:nbn:de:1111-2016030363994
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Legge, Francesco
- Paglia, Amelia
- D'Asta, Marco
- Fuoco, Gilda
- Scambia, Giovanni
- Ferrandina, Gabriella
- SpringerLink (Online service)
Other Objects (12)
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
Gemcitabine and Carboplatin in Intensively Pretreated Patients with Metastatic Breast Cancer
Lenalidomide in heavily pretreated refractory diffuse large B-cell lymphoma: a case report
Therapeutic options in heavily pretreated HIV-1 patients based on the genotypic resistance patterns
Preference of elderly patients’ to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Switch from enfuvirtide (ENF) to raltegravir (RAL): a simplification option for heavily pretreated HIV patients (pts)
An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
Megestrol Acetate for Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: An Old Answer for a New Problem
Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series
Penpulimab, an anti-PD-1 antibody, for heavily pretreated metastatic nasopharyngeal carcinoma: a single-arm phase II study
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
Gemcitabine and Carboplatin in Intensively Pretreated Patients with Metastatic Breast Cancer
Lenalidomide in heavily pretreated refractory diffuse large B-cell lymphoma: a case report
Therapeutic options in heavily pretreated HIV-1 patients based on the genotypic resistance patterns
Preference of elderly patients’ to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Switch from enfuvirtide (ENF) to raltegravir (RAL): a simplification option for heavily pretreated HIV patients (pts)
An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
Megestrol Acetate for Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: An Old Answer for a New Problem
Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series
Penpulimab, an anti-PD-1 antibody, for heavily pretreated metastatic nasopharyngeal carcinoma: a single-arm phase II study
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
Gemcitabine and Carboplatin in Intensively Pretreated Patients with Metastatic Breast Cancer
Lenalidomide in heavily pretreated refractory diffuse large B-cell lymphoma: a case report
Therapeutic options in heavily pretreated HIV-1 patients based on the genotypic resistance patterns
Preference of elderly patients’ to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Switch from enfuvirtide (ENF) to raltegravir (RAL): a simplification option for heavily pretreated HIV patients (pts)
An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
Megestrol Acetate for Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: An Old Answer for a New Problem
Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series